Provexis plc announced the filing of a new patent application relating to the use of Fruitflow to confer health benefits in modulating the gut microbiome of humans. This follows the completion of a successful human study, the results of which (as stated in the patent application) strongly support the use of Fruitflow for modulating gut microbiota to confer a number of health benefits.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.585 GBX | +1.74% | -10.00% | -10.00% |
2023 | Provexis plc Reports Earnings Results for the Half Year Ended September 30, 2023 | CI |
2023 | EARNINGS: Ebiquity swings to profit; SDX Energy swings to loss | AN |
1st Jan change | Capi. | |
---|---|---|
-10.00% | 16.57M | |
+16.80% | 8.43B | |
+7.94% | 7.8B | |
+15.02% | 6.82B | |
-6.75% | 3.74B | |
-4.77% | 3.77B | |
+4.41% | 1.44B | |
+20.28% | 1.04B | |
-12.85% | 890M | |
-15.63% | 812M |
- Stock Market
- Equities
- PXS Stock
- News Provexis plc
- Provexis plc Announces the Filing of New Patent Application